$AMRX news
The latest AMRX stock news: headlines, filings, AI summaries and sentiment for $AMRX, updated around the clock.
- Amneal Pharmaceuticals, Inc. - 10-Q Filing
- Amneal Pharmaceuticals Reports Strong Q3 2026 Results and Raises Full-Year Guidance
- Amneal Pharmaceuticals, Inc. - 8-K Filing
- Amneal Pharmaceuticals Reports Q2 2026 Earnings
- Amneal Pharmaceuticals Reports Q2 2026 Earnings with Strategic Shifts and Guidance Update
- Amneal Pharmaceuticals, Inc. - 8-K Filing
- Amneal Pharmaceuticals Reports Q2 2026 Earnings with Revenue Growth and Raised Guidance
- Amneal Pharmaceuticals, Inc. - 8-K Filing
- Amneal Pharmaceuticals Exceeds Q2 Earnings and Revenue Estimates
- Eli Lilly and Regeneron Selected for FDA PreCheck Pilot Program to Accelerate Drug Manufacturing Facility Reviews
- Zambon and Amneal Receive Positive CHMP Opinion for Parkinson's Disease Treatment Hopledo®
- Amneal Pharmaceuticals, Inc. - 10-Q Filing
- Amneal Pharmaceuticals, Inc. - 8-K Filing
- Amneal Pharmaceuticals, Inc. - 8-K Filing
- Amneal Reports Q2 2025 Earnings with Revenue Growth
- Amneal Pharmaceuticals (AMRX) Reports Q3 2025 Earnings Results
- Amneal Pharmaceuticals (AMRX) Reports Q2 2025 Earnings with Revenue Growth and Margin Improvements
- UBS Initiates Coverage on Amneal Pharmaceuticals with a Buy Rating
- Amneal Pharmaceuticals Announces Q1 2026 Earnings and Acquisition of Kashiv BioSciences
- Amneal Pharmaceuticals Q1 2026 Earnings Call Summary